Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
The company also reported adjusted EBITDA of $82.2 million in the second quarter compared to $39.3 million for the same period in 2024
Testing at 0.63 ATA demonstrated a statistically significant reduction in cognition in the TBI group compared to the matched controls, and this value was equivalent to acutely concussed patients
PlexusDx provides access to FDA-studied weight loss medications starting at $129 monthly, serving all 50 states without membership fees or insurance mandates
Build a de-escalation pathway from day one
US$ 29.54
US$ 26.46
US$ 29.24
US$ 22.50
